Irritable Bowel Syndrome With Constipation (IBS-C)

Gastroenterology

7 drugs in development·4 companies·3 clinical trials

Drug Pipeline by Phase

Approved(4)

Drug	Company
IBSRELA	ARDELYX, INC. (ARDX)
LINZESS	IRONWOOD PHARMACEUTICALS INC (IRWD)
trulance	SYNERGY PHARMACEUTICALS LLC (SGYP)
Trulance	Bausch Health Companies Inc. (BHC)

Phase 3(2)

Drug	Company
tenapanor (CIC label extension / ACCEL (ten-03-301))	ARDELYX, INC. (ARDX)
tenapanor 25 mg bid	ARDELYX, INC. (ARDX)

Phase 2(1)

Drug	Company
tenapanor	ARDELYX, INC. (ARDX)

BioSniper tracks 7 drugs in development for Irritable Bowel Syndrome With Constipation (IBS-C) across 4 companies.

There are 3 clinical trials targeting Irritable Bowel Syndrome With Constipation (IBS-C) tracked by BioSniper.

Full trial data, competitive analysis, and AI-powered pipeline tracking.